Targeting Inflammation By Anthocyanins As The Novel Therapeutic Potential For Chronic Diseases: An Update Part 2
Apr 29, 2022
Please click oscar.xiao@wecistanche.com for more information
7. Clinical Studies on Anthocyanin Interventions—An Update from the Last 5 Years
Anthocyanins have been widely substantiated by preclinical evidence as compounds with metabolic regulatory effects on LGCI that may contribute to preventing or delaying the onset of cancer, diabetes, Alzheimer's disease, cardiovascular, pulmonary, and autoimmune diseases, but the evidence in humans is still limited. However, numerous randomized controlled trials have been conducted lately. They mostly focus on the anti-inflammatory effects of anthocyanins and their impact on the cardiovascular system and cognitive functions in both healthy and chronic disease populations (Supplementary Table S1).In this update, we present the clinical studies that provide us with the strongest evidence for the role of additional anthocyanin intakes in the manifestation of inflammation in both chronic diseases and healthy subjects.

Please click here to know more
7.1.Anthocyanins and Inflammation Markers Metabolic Disorders
Low-grade chronic inflammation is one of the primary mechanisms of cardiovascular diseases(CVDs) and plays an essential role in the initiation and progression of CVDs but is also related to other forms of CVDs, such as hypertension, and dyslipidemia, peripheral arterial disease, coronary artery disease, and ischemic stroke. This group of disorders is still the leading cause of morbidity and mortality worldwide [86,87]. Therefore, identifying modifiable risk factors and understanding the importance of a natural food supplement that could effectively lower LGCI would contribute to the prevention and treatment of MetS, T2DM, and obesity.
The beneficial effect of anthocyanins among MetS individuals was widely investigated. flavonoids In a clinical control trial, patients with MetS who consumed diets supplemented with 320 mg of anthocyanins for four weeks displayed reductions in the serum fasting blood glucose by 13%, triglyceride (TG)by 25%, and low-density lipoprotein cholesterol (LDL-C) by 33%, and attenuations in hs-CRP level by 28% among females, as compared to healthy subjects [88]. Dietary supplementation of anthocyanins (320 mg/daily)was also associated with inhibiting the expression of pro-inflammatory genes and factors related to NF-kB pathways including TNF-αx(by -28% and-15%),IL-6(-16.1%and-13.6%),IL-1A (-21.5% and-12.9%),platelet endothelial cell adhesion molecule-1(PCAM-1)(-15% and -17.5%), and COX-2(-26% and-27%) in both MetS and control group, respectively [89]. The transcription factor NF-kB regulates cellular immune responses to infection and oxidative stress as a pivotal mediator of the inflammatory response. herba cistanches The activation of NF-kB leads to the induction of pro-inflammatory mediator expression, including inducible COX-2, iNOS, NO, IL-1, IL-6, TNF-α, adhesion molecules, and chemokines [90]. Anthocyanin supplementation, which was shown to have beneficial effects on inflammatory cascade, may have a role in the development of therapeutic strategies based on NF-kB inhibition.

Cistanche can improve immunity
In line with the results above, the anti-inflammatory effects of anthocyanins were also reported in pilot randomized, placebo-controlled clinical trials [91,92]. Twelve-week dietary supplementation with Acai berry beverages decreased two biomarkers for inflammation and oxidative stress, the plasma level of interferon-gamma (IFN-y), and urinary level of 8-isoprostane in MetSindividuals [91]. Further, Montmorency tart cherry juice attenuated the oxidized low-density lipoprotein(OxyLDL) and soluble vascular cell adhesion molecule-1(VCAM-1) protein, which is closely associated with the progression of various immunological disorders [92,93].
Current research provides links between dyslipidemia and elevated levels of low-grade chronic inflammatory cytokines, such as interleukin I-6, TNF-α, and CRP [94].In a dose-response randomized control trial (RCT), 12-week anthocyanin supplementation was the most efficient and positively improved the anti-oxidative and anti-inflammatory capacity by reducing serum of IL-6 by 40%, TNF-αby 21%, malondialdehyde (MDA)by 20%, urine 8-isoPGF2a by 37%, and 8-hydroxy-2'-deoxyguanosine(8-OHdG)by 36%and significantly improving T-SOD in dyslipidemic individuals. The daily dosage of 320 mg was the most efficient [95]. It has also been well documented that obesity results in the secretion of strong pro-inflammatory and regulatory mediators, as well as cytokines or chemokines [8]. The anti-inflammatory effects of anthocyanins were also reported in patients with obesity or overweight in both short and long-term interventions. Daily consumption of dried jucara pulp(~131.2 mg of anthocyanins) for 6 weeks reduced inflammation gene and protein expression in monocytes in obese patients [96]. Further, whole purple wheat(containing not only anthocyanins but also other phytochemicals and fiber) attenuated the inflammatory response in obese subjects, where a reduction in IL-6 and TNF-α was observed [97]. Recent clinical studies that analyzed the effect of acute meal supplementation with strawberries reported divergent results concerning IL-6 levels among patients with overweight and obesity 198,99]. However, all data presented above seem to use anthocyanins as a potential tool against obesity-related sub-clinical inflammation.
In the last 5 years, there has been a limited number of clinical studies in which pre-diabetic or T2DM volunteers are supplemented with anthocyanin-rich products, and different parameters in relation to diabetes and oxidative and inflammatory markers are measured [67]. Over a 4-week period, anthocyanin supplementation had beneficial effects on such pro-inflammatory molecules as IL-6, IL-18, and TNF-α in T2DM patients [100]. Consistently, these results further show that anthocyanins supplements may be useful in amelioration inflammation by favorably decreasing the secretion of inflammatory biomarkers.
7.2.Anthocyanins and Inflammation Markers in Healthy and Physical Active Individuals
Regarding anthocyanins' effects on lipid profile, inflammation, and oxidative stress, their effect is more noteworthy in hyperlipidemic and obese patients than in healthy subjects. This results from the fact that healthy subjects' baseline measures of oxidative stress and inflammation are relatively low, making it more difficult to detect any changes as a result of anthocyanin supplementation. However, many clinical trials evaluated the modulation of oxidative stress biomarkers in healthy subjects, which was manifested by increasing the activities of the antioxidant enzymes and total antioxidant capacity [101-105].
A wide variety of anthocyanin supplements, particularly those from fruits such as berries, strawberries, acai berries, raspberry, or other plant extracts, have been used in healthy individuals for their effects on inflammatory agents. De Lizet al. [102] determined the effect of the administration of acai juice on oxidative stress biomarkers in healthy adults. Oxidative stress was assessed, including total antioxidant capacity (TAC) and oxidative stress index (OSI), where is the sum of both enzymatic and nonenzymatic antioxidants, and OSI indicates the relationship between antioxidant mechanisms and oxidant concentrations [106]Acaijuice in 4-week intervention promoted increases in TACby 67% and attenuated OSI by 56% in healthy adults. Further, anthocyanins from acai enhanced the erythrocytes catalase (CAT) and glutathione peroxidase(GPx) enzyme activities compared to baseline [102]. life extension cistanche Interestingly, the concentrations of high-density lipoprotein cholesterol(HDL-c)by nearly 8% were observed, which indicated the positive effects of regular consumption of acai juice on cardiovascular health. Similarly, a one-time combination of anthocyanins and bromelain supplementation among 18 healthy adults improved TAC, oxygen utility capacity, and brachial artery flow-mediated dilation (FMD)[105]. These results suggest that anthocyanin intake may be an effective nutritional therapy for improving vascular health.
Other clinical studies were performed with anthocyanin-rich foods as sources of anthocyanins. It must be emphasized that natural sources of these substances consist of many other protective substances such as fiber or other polyphenols. Moreover, phytochemicals and vitamins found in fruits and vegetables could interact synergistically or antagonistically with anthocyanins, thereby enhancing or decreasing the antioxidant activity of these compounds [21]. In healthy individuals, intake of yogurt enriched with anthocyanins from raspberry rice(Oryza Sativa L.)significantly increased plasma ferric reducing ability of plasma (FRAP), Trolox equivalent antioxidant capacity (TEAC), and oxygen radical absorbance capacity(ORAC)and reduced plasma MDA, which is a well-known lipid peroxidation product [103].

Not all reports provide evidence of favorable effects of anthocyanin on anti-inflammatory and oxidative stress markers concentrations in healthy subjects. Some long-term randomized clinical trial reports indicated that 60 mg/day supplementation of anthocyanins for eight months among postmenopausal women produces favorable effects on glucose levels. However, no changes in inflammatory and antioxidant parameters, such as CRP, I-6, VCAM-1, intercellular adhesion molecule-1 (IAM-1), monocyte chemoattractant protein-1(MCP-1), or matrix metalloproteinases 2(MMP-2) and MMP-9, were observed [107]. Similarly, no changes in plasma adiponectin, IL-6, IL-1β, MCP-1, TNFa, or CRP were ob-
served among healthy former smokers in 12-week, 500 mg Aronia extract supplementation. However, a reduction in plasma total cholesterol (TC) and LDL-C was observed [108].
There has also been an interest in the properties of anthocyanins in the alteration of inflammation processes related to physical activity. Given these data, it is tempting to speculate that consumption of black currant nectar during eccentric exercise attenuates muscle damage and inflammation by reducing creatine kinase (markers of muscle damage) and positive changes in ORAC and IL-6 concentrations [109].
7.3. Anthocyanins and Neuroinflammation
It is well known that antioxidant defenses are unbalanced in mostly neurological pathologies [17,110,111]. Anthocyanins are unique neuroprotective agents that have been shown in animals to modulate neuroinflammation, and interest in their use as therapeutics for neurodegeneration has grown in recent years [111].
In a recent clinical study, anthocyanins and their metabolites appeared to ameliorate cognitive decline in aging adults, with either slight or no effects on pro-inflammatory markers. Do Rosario et al. [112] showed that 8-week anthocyanins intake decreased the serum concentrations of TNF-α in older adults diagnosed with mild cognitive impairment (MCI). However, no other inflammatory biomarkers have been found. In turn, Kent et al. [113]evaluated the protective effects of 12-week consumption of 200 mL/day of anthocyanins-rich cherry juice containing 138 mg of anthocyanins in adults over 70 years with mild-to-moderate dementia. Cherry juice improved verbal fluency, short-term memory, and long-term memory. Moreover, the intake of juice promoted a decrease in systolic blood pressure. However, inflammatory markers like CRP and IL-6 were not altered. Similarly, blueberry extract (equivalent to approximately 387 mg of anthocyanidins) in-take for 12 weeks enhanced working memory and cerebral brain perfusion in healthy older adults [114]. maca ginseng cistanche seahorse Corresponding to Kent et al.'s[113] results, anthocyanins supplementation did not affect hsCRP. However, all authors highlighted that the short intervention length and the small number of participants have been the main limitations of the studies presented above.
7.4.Anthocyanins and Other Inflammatory Markers Reports
Recent clinical studies have also reported anthocyanin effects on inflammation in patients with insomnia, chronic kidney diseases, and patients after acute myocardial infarction [115-117]. In a placebo-controlled, crossover pilot study conducted among patients with insomnia, daily consumption of cherry juice decreased the level of PGE-2 and indicated an inhibition of the enzyme indoleamine 2, 3 dioxygenase (IDO). Inhibition of IDO may decrease inflammation [118].In addition, the sleep time was extended by 84 min among participants [117]. Interestingly, supplementation of extruded sorghum breakfast cereal combined with unfermented probiotic milk decreased the CRP and malondialdehyde serum levels and increased the TAC and SOD enzyme levels in patients with chronic kidney disease, suggesting that anthocyanin and other phytochemicals may protect from inflammation and oxidative stress in these group of patients [116]. In turn, findings from the RCT suggested that bilberries may have clinically relevant beneficial effects on patients after acute MI. However, the inflammatory markers such as hs-CRP did not change with bilberry supplementation [115].
8. Summary
Low-grade chronic inflammation is a key factor in the pathogenesis of many chronic diseases. Therefore, identifying modifiable risk factors that could effectively lower LGCI would contribute to the prevention of chronic disease.
This narrative review summarizes the main clinical studies in the context of the anti-inflammatory and anti-oxidative role of anthocyanins in both health and disease. Growing numbers of preclinical studies suggest its modulatory effect on inflammation pathways. micronized purified flavonoid fraction tablet uses Nevertheless, quantifying the effect of anthocyanins on inflammation in randomized control trials is hard to assess. The evidence that supports the direct anti-inflammatory role of anthocyanins is relatively scarce or of low quality. However, it supports the author-cyanins' role in regulating inflammation. Over the past five years, at least 29 clinical studies have evaluated the relationship between anthocyanins supplementation and inflammation. However, inconsistencies between the result of RCIs and meta-analyses have been observed. The main limitations of the presented clinical data are the short length of observation, small samples, and a wide variety and dosages of anthocyanin supplements that were used. It must be underlined that anthocyanins interventions have been more widely investigated in the treatment of metabolic outcomes. Human studies have reported lower LDL-cholesterol and triglycerides and increased HDL cholesterol. Thus, the data support an indirect and beneficial role of anthocyanins in improving LCGI.
Regarding anthocyanins' effects on inflammatory markers, there is a need for long-term clinical trials allowing for the long preclinical phase or quantifiable progression of inflammation. Future research and intervention should also take into account the validation of the reduction of inflammatory markers by these compounds as well as other potential regulatory effects such as gut microbiota activity, on which anthocyanin bioactivity depends. Furthermore, strategies for improving techniques to evaluate gut microbiota's impact on the bioavailability of anthocyanins are needed. Additionally, a better understanding of the role of anthocyanins in inflammation could not be fully established without knowledge of the effects of treatment of pure anthocyanins. oteflavonoid The synthesis of pure anthocyanins for research purposes remains crucial. Further translational research is necessary to understand the pharmacological actions of anthocyanins in humans.
The present review can clinicians and other health care professionals in understanding the importance of both supplemental and natural sources of anthocyanins in the LGCI and inflammatory status of patients. Anthocyanins treatment as a natural therapeutic strategy, free of side effects, could represent a useful tool in the prevention and treatment of low-grade chronic inflammation.

Supplementary Materials: The following are available online. Table S1: The summary of(A) clinical trials in particular disorders and (B)meta-analyses. References[119-124] are cited in the supplementary materials.
Author Contributions: Conceptualization and methodology, T.D.; writing—original draft preparation, A.K.; writing—review and editing, T.D. All authors have read and agreed to the published version of the manuscript.
Funding: This research received no external funding. Data Availability Statement: Not applicable.
Conflicts of Interest: The authors declare no conflict of interest.
This article is extracted from Molecules 2021, 26, 4380. https://doi.org/10.3390/molecules26144380 https://www.mdpi.com/journal/molecules






